Review



mct 1 4 inhibitor  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress mct 1 4 inhibitor
    Mct 1 4 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 75 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pm41128634-43-31-29?v=MedChemExpress
    Average 95 stars, based on 75 article reviews
    mct 1 4 inhibitor - by Bioz Stars, 2026-07
    95/100 stars

    Images



    Similar Products

    95
    MedChemExpress mct 1 4 inhibitor
    Mct 1 4 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pm41128634-43-31-29?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    mct 1 4 inhibitor - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress mct 1 inhibitor
    Mct 1 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pm41128634-43-20-29?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    mct 1 inhibitor - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    90
    AstraZeneca ltd monocarboxylate transporters (mct) 1 inhibitors
    Monocarboxylate Transporters (Mct) 1 Inhibitors, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pm37688395-207-17-15?v=AstraZeneca+ltd
    Average 90 stars, based on 1 article reviews
    monocarboxylate transporters (mct) 1 inhibitors - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    95
    Tocris mct 1 2 inhibitor ar c155858
    Mct 1 2 Inhibitor Ar C155858, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pm37418488-301-0-13?v=Tocris
    Average 95 stars, based on 1 article reviews
    mct 1 2 inhibitor ar c155858 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    90
    AstraZeneca ltd mct-1 inhibitor azd3965
    Promising metabolic drugs currently explored for the treatment of CRPC in combination with ADT, AR signaling inhibitors, or chemotherapy
    Mct 1 Inhibitor Azd3965, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pmc09019185-181-9-3?v=AstraZeneca+ltd
    Average 90 stars, based on 1 article reviews
    mct-1 inhibitor azd3965 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    95
    MedChemExpress mct 1 inhibitor azd3965
    Promising metabolic drugs currently explored for the treatment of CRPC in combination with ADT, AR signaling inhibitors, or chemotherapy
    Mct 1 Inhibitor Azd3965, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mct+1+inhibitor/pmc07104346-95-43-46?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    mct 1 inhibitor azd3965 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    Image Search Results


    Promising metabolic drugs currently explored for the treatment of CRPC in combination with ADT, AR signaling inhibitors, or chemotherapy

    Journal: Cancer Drug Resistance

    Article Title: Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer

    doi: 10.20517/cdr.2020.54

    Figure Lengend Snippet: Promising metabolic drugs currently explored for the treatment of CRPC in combination with ADT, AR signaling inhibitors, or chemotherapy

    Article Snippet: Regarding MCT inhibitors, AstraZeneca has recently developed a specific MCT-1 inhibitor (AZD3965) that is currently in a phase 1 clinical trial (NCT01791595), while MCT-4 inhibitors are still in the discovery phase .

    Techniques: Inhibition, Activation Assay, Targeted Gene Expression, Comparison